Dr. Goly Abivardi

Money Moves

Leads a newly public company trading below its IPO price

Dentists have handled early cavities the same way since the drill arrived in the 1950s: watch the lesion, then fill it. vVARDIS raised $175 million on the New York Stock Exchange on Nov. 13 to sell them a third option, a peptide gel called Curodont that rebuilds enamel without drilling.

Updated 1 hour ago